Evidence map›Paper›PMID 34588460›Full record

ArticleNature communications2021

Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity.

Yvan Butera, Enatha Mukantwari, Maria Artesi, Jeanne d'arc Umuringa, Áine Niamh O'Toole, Verity Hill, Stefan Rooke, Samuel Leandro Hong, Simon Dellicour, Onesphore Majyambere and 26 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Yvan Butera *Center for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Enatha Mukantwari *National Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Maria Artesi *Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium.
Jeanne d'arc Umuringa *National Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Áine Niamh O'TooleInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, Scotland.ORCID 0000-0001-8083-474X
Verity HillInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, Scotland.ORCID 0000-0002-3509-8146
Stefan RookeInstitute of Evolutionary Biology, University of Edinburgh, Edinburgh, Scotland.
Samuel Leandro HongDepartment of Microbiology, Immunology and Transplantation, Rega Institute KU Leuven, Leuven, Belgium.ORCID 0000-0001-6354-4943
Simon DellicourDepartment of Microbiology, Immunology and Transplantation, Rega Institute KU Leuven, Leuven, Belgium.ORCID 0000-0001-9558-1052
Onesphore MajyambereNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Sebastien BontemsDepartment of Clinical Microbiology, University Hospital of Liège, Liège, Belgium.
Bouchra BoujemlaLaboratory of Human Genetics, GIGA Research Institute, Liège, Belgium.
Josh QuickUniversity of Birmingham, Birmingham, England.
Paola Cristina ResendeUniversity College London, London, England.
Nick LomanUniversity of Birmingham, Birmingham, England.
Esperance UmumararunguNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Alice KabandaNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Marylin Milumbu MurindahabiRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Patrick TuyisengeNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.ORCID 0000-0003-2609-3797
Misbah GasheguRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Jean Paul RwabihamaRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Reuben SindayihebaNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Djordje GikicRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.ORCID 0000-0002-9030-6534
Jacob SouopguiCenter for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.ORCID 0000-0003-1526-4431
Wilfred NdifonAfrican Institute for Mathematical Sciences, Kigali, Rwanda.
Robert RutayisireRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Swaibu GatareRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Tharcisse MpungaRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Daniel NgamijeRwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Vincent Bours *Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium.
Andrew Rambaut *Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, Scotland.ORCID 0000-0003-4337-3707
Sabin Nsanzimana *Rwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Guy Baele *Department of Microbiology, Immunology and Transplantation, Rega Institute KU Leuven, Leuven, Belgium. guy.baele@kuleuven.be.ORCID 0000-0002-1915-7732
Keith Durkin *Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium. kdurkin@uliege.be.ORCID 0000-0001-7475-6618
Leon Mutesa *Center for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda. lmutesa@gmail.com.ORCID 0000-0002-5308-3706
Nadine Rujeni *Rwanda National Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda. nrujeni@gmail.com.ORCID 0000-0002-1805-1768

Funding

Medical Research Council MR/S035362/1Wellcome Trust
6 · The paper itself

Abstract

COVID-19 transmission rates are often linked to locally circulating strains of SARS-CoV-2. Here we describe 203 SARS-CoV-2 whole genome sequences analyzed from strains circulating in Rwanda from May 2020 to February 2021. In particular, we report a shift in variant distribution towards the emerging sub-lineage A.23.1 that is currently dominating. Furthermore, we report the detection of the first Rwandan cases of the B.1.1.7 and B.1.351 variants of concern among incoming travelers tested at Kigali International Airport. To assess the importance of viral introductions from neighboring countries and local transmission, we exploit available individual travel history metadata to inform spatio-temporal phylogeographic inference, enabling us to take into account infections from unsampled locations. We uncover an important role of neighboring countries in seeding introductions into Rwanda, including those from which no genomic sequences were available. Our results highlight the importance of systematic genomic surveillance and regional collaborations for a durable response towards combating COVID-19.

Indexed as

Travel-Related IllnessAdultCOVID-19Epidemiological MonitoringFemaleGenome, ViralHumansMalePhylogenyPhylogeographyRNA, ViralRwandaSARS-CoV-2Whole Genome SequencingRNA, Viral

Identifiers

PMID34588460
PMCPMC8481346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.